Bioventure Creation Fund to raise $100 mln venture-capital fund


Bioventure Creation Fund has set out to raise a $100 million venture-capital fund, according to a filing with the SEC.

Brian Taylor Slingsby, CEO of the Global Health Innovative Technology Fund, is listed as a managing director of the Tokyo-based fund.

The filing is available here.

 

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.